about
Potential Mechanisms for IgG4 Inhibition of Immediate Hypersensitivity ReactionsThe Cloning and Expression of Human Monoclonal Antibodies: Implications for Allergen ImmunotherapyIgE binds asymmetrically to its B cell receptor CD23A tool kit for rapid cloning and expression of recombinant antibodies.Influence of seasonal exposure to grass pollen on local and peripheral blood IgE repertoires in patients with allergic rhinitisIgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens.Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes.Epitope specificity determines cross-protection of a SIT-induced IgG4 antibodyInhibition of allergen-dependent IgE activity by antibodies of the same specificity but different class.Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps.Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.A Phl p 7-specific IgG4 antibody inhibits allergic patients IgE cross-reactivity to allergens from the EF-hand family: importance of affinity and degree of cross-reactivityAllergen specificity of IgG4-expressing B cells in patients with grass pollen allergy undergoing immunotherapyStructure of a patient-derived antibody in complex with allergen reveals simultaneous conventional and superantigen-like recognitionLong-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodiesSerum immunologic markers for monitoring allergen-specific immunotherapyRhinitis with negative skin tests and absent serum allergen-specific IgE: more evidence for local IgE?Distinct microbial and immune niches of the human colonIsolation and Characterization of Lymphocytes from Human Mucosal BiopsiesInterplay between Affinity and Valency in Effector Cell Degranulation: A Model System with Polcalcin Allergens and Human Patient-Derived IgE AntibodiesOrchestration of immunoglobulin isotypes, subclasses, and specificities in patients receiving intravenous IgG or subcutaneous immunotherapy and those with chronic rhinosinusitis with nasal polyps: Toward precision medicineDupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps
P50
Q26764848-146B08DB-A490-45AE-A4F2-738C1073E185Q26771289-F1413093-DC1C-422C-ADE4-36468257A158Q30843434-3395C176-11D1-4DBD-BE18-0A238EA87045Q33970343-CE783AE6-4326-4B85-8F4B-969CFD45ABCEQ34121184-E0820F76-3CD2-481E-805A-30B58A3B1D85Q35566586-F001AFE7-1E8F-483A-8BF6-CC603ADB26BFQ36379784-71452EF9-3243-4578-9385-6A0F5508EBC2Q36472423-8CCCC75C-7B49-43DB-AC62-E45F047E3050Q37105631-D92647DE-991C-4F76-A3A8-7AAAA9BC9313Q37737520-C99FFED7-00BB-4288-91B0-13E9BE0AF3CBQ40023867-75D5CFD5-41DD-47FE-AC6A-F805600E2358Q58428715-A1C7816B-6DCF-4E36-9252-3A8C9C70BE64Q58428742-DA6E3F32-A876-46CB-8DD7-BD5F6B4388C7Q58700268-0618F1A2-8843-4735-ADD0-ACE9650BF9A6Q60312277-CC97EB42-0FF4-4AF5-8DC7-B09008C337E0Q84003287-01A8AB1A-0A8A-45E2-96CB-D430537252BFQ84862959-94D240F0-9B30-4C94-96E4-2B0FB1D168C7Q89748559-93C364D1-5431-4662-A986-7B91672BC9E3Q92610101-6794F460-6916-4842-8AD4-34B3F5A594C3Q92964296-D5148A7A-FB72-4023-B586-7A03D26C1E7FQ93113220-AC30EF45-B2DA-42C5-8C78-54D1AD16D51FQ95641851-4D231A95-E3B4-41C1-81B0-82EAADB8A255
P50
description
researcher ORCID ID = 0000-0002-2252-4636
@en
name
Louisa K James
@ast
Louisa K James
@en
Louisa K James
@es
Louisa K James
@nl
type
label
Louisa K James
@ast
Louisa K James
@en
Louisa K James
@es
Louisa K James
@nl
prefLabel
Louisa K James
@ast
Louisa K James
@en
Louisa K James
@es
Louisa K James
@nl
P1153
23982451800
P31
P496
0000-0002-2252-4636